GENERAl, R.R.O. 1990, Reg. 935

Section 1

Cite as GENERAl, R.R.O. 1990, Reg. 935, s. 1 · current to November 11, 2026 · consolidated from March 7, 2024 · read from e-Laws on November 16, 2026

The text

(1) In this Regulation, “generic line extension drug product” has the same meaning as in Ontario Regulation 201/96 (General) made under the Ontario Drug Benefit Act; (“produit médicamenteux générique d’élargissement de gamme”) “original product” means the original source of a drug product in a particular strength and dosage form; (“produit d’origine”) “production size lot” means the amount of finished product that is made from the minimum quantity of raw materials specified in a formula that can be processed using full sized production equipment into a dosage form that meets the specifications for the finished product. (“lot de fabrication”) (1.1) Revoked: O. Reg. 54/06, s. 1 (2). (1.2), (1.3) Revoked: O. Reg. 458/06, s. 1 (4). (2) For the purposes of subsection 1 (2) of the Act, “therapeutic substitution” means the substitution of a drug that contains chemically different active ingredients that are considered to be therapeutically equivalent, without authorization from a person authorized to prescribe drugs within the scope of his or her practice of a health profession. O. Reg. 458/06, s. 1 (4). (3) Revoked: O. Reg. 221/10, s. 1. (4) Revoked: O. Reg. 458/06, s. 1 (4). (5) Revoked: O. Reg. 485/05, s. 1 (2). (6) Revoked: O. Reg. 458/06, s. 1 (4).
Read the GENERAl on e-Laws ↗

Made under Drug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23.